Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer

Vrdoljak Eduard and Marschner N. and Zielinski Christoph Carl and Gligorov Joseph and Cortes Javier and Puglisi Fabio and Aapro Matti S. and Fallowfield Lesley J. and Fontana Andrea and Inbar Moshe Josef and Kahán Zsuzsanna and Welt Anja and Lévy Christelle and Brain Étienne G.C. and Pivot Xavier B.: Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer.
ANNALS OF ONCOLOGY, 27 (11). pp. 2046-2052. ISSN 0923-7534 (2016)

[thumbnail of mdw316.pdf]
Preview
Text
mdw316.pdf - Published Version

Download (261kB) | Preview
Creators:
Vrdoljak Eduard
Marschner N.
Zielinski Christoph Carl
Gligorov Joseph
Cortes Javier
Puglisi Fabio
Aapro Matti S.
Fallowfield Lesley J.
Fontana Andrea
Inbar Moshe Josef
Kahán Zsuzsanna MTMT
Welt Anja
Lévy Christelle
Brain Étienne G.C.
Pivot Xavier B.
Item Type: Journal Article
Szerzők száma: 20
Journal or Publication Title: ANNALS OF ONCOLOGY
Date: 2016
Volume: 27
Number: 11
Page Range: pp. 2046-2052
ISSN: 0923-7534
Faculty/Unit: Faculty of Medicine
Institution: University of Szeged (2000-)
Language: English
MTMT rekordazonosító: 3257982
DOI azonosító: https://doi.org/10.1093/annonc/mdw316
Date Deposited: 2017. Aug. 30. 11:19
Last Modified: 2020. Jan. 17. 14:20
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/11866
Web of Science® Times Cited: 30 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year